Stocks and Investing Stocks and Investing
Tue, March 14, 2023
Mon, March 13, 2023

Raghuram Selvaraju Reiterated (VRNA) at Strong Buy and Held Target at $32 on, Mar 13th, 2023


Published on 2024-10-28 02:14:58 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $32 on, Mar 13th, 2023.

Raghuram has made no other calls on VRNA in the last 4 months.



There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Increased Target to $28 on, Tuesday, December 20th, 2022
  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $26 on, Tuesday, December 20th, 2022

Contributing Sources